Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 5, 2004

View Archived Issues

NO-donating NSAIDs may attenuate neuroinflammation in Alzheimer's disease

New insight into curcumin action against amyloid pathology

Soy derivative phyto SERM relieves menopausal symptoms and improves BMD without side effects

Novel MAO-B inhibitors developed by Roche researchers

Merck KGaA describes new derivatives of the kappa opioid agonist asimadoline

Novel PDE4D inhibitors prepared and tested by Novartis scientists

New benzimidazole-based gastric antisecretory agents claimed by Altana Pharma

Mitsubishi Pharma and Sanofi-Synthelabo present new TPK1 inhibitors

Alcon patent covers new 5-HT2 agonists for glaucoma therapy

Cytovia researchers identify new caspase activators

CV Therapeutics initiates approval-enabling study of Ranexa

Enrollment completed in phase I colorectal cancer study of Cotara

Organon and Meiji Seika sign Japanese agreement for mirtazapine

Meiact AS granules launched in Japan

Remofovir mesylate enters phase II

Research group to study RPI-78M in MS assays

Pfizer to use Nektar PEGylation technology in drug development

Approvable letter for Lumigan-timolol combination

TRX4 evaluated in new phase I study for psoriasis

sNDA submission for Merrem for complicated skin and skin structure infections

VivaGel phase I study moves into third stage of dosing

La Jolla reaches agreement for phase IV Riquent study

Targeting IP-10 for IBD: Protein Design Labs characterizes antibody for clinical development

Novel small molecule immunomodulating agent for eczema/psoriasis therapy

Potent orally active antiinflammatory agent by Bristol-Myers Squibb

First evidence of effective mGlu2 receptor potentiators for schizophrenia therapy by Merck

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Rare earth: Biomarin to use global reach post-$4.8B Amicus buy
BioWorld
Biomarin Pharmaceutical Inc. followed up its May takeover of Inozyme Pharma Inc. with a much larger agreement to acquire Amicus Therapeutics Inc. for $14.50 per...